NAscence Bio-Innovation Group
The NAscence Group in our Pharmaceutical Industry practice works collaboratively with companies of all types – private and public, emerging Biotech and "Big Pharma" – to help them spawn innovative products that will flourish in a high-stakes environment.
The Challenges of Bringing New Pharmaceutical Products to Market
Innovation is the Pharmaceutical Industry’s lifeblood but the process of discovering and commercializing new products is burdened by fundamental uncertainty, lengthy development cycles, and frequent course correction. Innovative products and technology platforms require enormous investment, and the risks are as high as the potential return. So are the challenges.
Keys to Product Innovation Success
What are the keys to maximizing the commercial success of new products? Innovative science and horizon thinking, of course, but also an ability to navigate the regulatory process and a shrewd, well-informed commercialization strategy. All these require cost-effective, trustworthy marketing intelligence that informs the development process to support sound, timely decisions from Pre-clinical to Launch.
The NAscence Group
The NAscence Group helps clients make effective, timely decisions and wring value from their market research investment by ensuring that they understand what research they need to do, when they need to do it, and what it all means for the product development process.
- Identifying information needs and available resources to build a research program and timeline
- Framing that program in the context of an overall development and commercialization plan
- Guiding clients toward appropriate data sources and research methodologies
- Implementing milestone studies and extracting analytic insights
- Integrating primary and secondary data coherently to define opportunities, risks, and options
- Applying those insights to help client teams make well-grounded strategic decisions
NAscence Group Resources
The NAscence Group is a team of skilled and experienced research professionals at National Analysts Worldwide who specialize in guiding new products through the development process from pre-clinical through FDA submission and launch. We bring interdisciplinary training drawn from the biological sciences, marketing sciences, and social sciences; decades of experience in commercializing healthcare innovation; and an approach to sophistication with reassuring practicality. We are knowledgeable about drug chemistry and clinical practice in virtually every field of medicine. We are collaborative, flexible, and customer-focused. We are accustomed to working with CEOs, Senior Marketing Managers, Clinical Program Directors, Chief Medical Officers, Commercial Strategy Leaders and Market Researchers, so we can adjust our perspective and service offerings to accommodate the size and infrastructure of client organizations. And we are recognized leaders in our industry, having pioneered the field of healthcare market research many decades ago. Our experience includes gene therapies, stem cell therapeutics, cell-based and traditional vaccines, monoclonal antibodies, targeted small molecules, diagnostics and biomarkers.
NAscence Group Offerings
Whether you seek assistance with a single project or an ongoing collaboration, we offer a comprehensive array of research and analytic techniques, structured programmatically for our clients to fit their organizational budgets and product development stage. We support every key decision along the development path and every kind of analysis, and we offer our clients the kind of committed "thought partnership" that produces lasting relationships.
- Market Landscape Mapping
- Opportunity Assessment
- Early Concept Screening
- Forecasting
- Pricing Support
- Clinical Trials Design to Optimize Product Labeling
- Strategic Positioning
- Segmentation and Targeting
As a team of specialized practitioners within National Analysts Worldwide, the NAscence Group draws on the extensive resources of the firm to meet the needs of our clients. Each year, we conduct more than 30 assignments designed to support new product development in the Life Sciences using an array of methods. Our modelers and our moderators are all on staff, so research problems are always addressed by a well-integrated team with a deep understanding of the issues. We also have close ties with consultants specializing in commercialization strategy who can step into that role for small companies not yet fully staffed. Resources include:
- Thought Leader Panels and Advisory Boards
- Qualitative Depth Interviews with "grass-roots" Practitioners and other Healthcare Stakeholders
- Survey Research using all appropriate methodologies
- Advanced Choice Modeling (conjoint) and all Regression-based Models
- Prescience provides comprehensive and powerful decision support for the Pharmaceutical Industry by enabling clients to take advantage of custom models and modeling applications that reflect the depth of our industry experience and our advanced analytics. Specialized modeling services include:
- Demand Forecasts (propelled by a suite of choice models) for new molecules and platform technologies
- Clinical Program Optimization Models designed to guide trials strategy
- Integrated MD-Patient Demand Models that reflect new "democratic" models of therapy decision-making
- DTC ROI Models to validate investment decisions and optimize media strategies
Prescience modeling architecture is both sturdy and elegant; it can be designed to sit atop complex Bayesian choice model platforms and accommodate a very large array of multi-year assumptions about the behaviors and interactions of physicians, payors, patients, and competitors. Ultimately, what sets it apart is not merely design finesse and sophistication, but the way in which decades of real world experience in pharmaceutical marketing inform and guide interpretation of the output. Prescience is not merely a set of advanced algorithms and high-tech modeling mechanics.
It's a thoughtful and inventive problem-solving process powered by creative analytics and fueled by keen sensitivity to trends, changing market structures, and evolving medical paradigms.